Research with human participants

Overview of medical research in the Netherlands

Medication for comorbid diseases in end-of-life care in Dutch palliative care facilities

Published:
Last updated:

to focus on the patient objectives about medication use for comorbid diseases at the end of life.

Download: PDF | XML
Ethical review
Approved WMO
Status
Recruiting
Health condition type
Other condition
Study type
Observational non invasive

ID

NL-OMON37091

Source

ToetsingOnline

Brief title

medication for comorbid diseaeses in end-of-life care

Condition

  • Other condition

Synonym

terminal care

Health condition

terminale patienten in hospices met diverse beelden

Research involving

Human

Sponsors and support

Primary sponsor :
stichting Groenhuysen
Source(s) of monetary or material Support :
stichting Groenhuysen;Roosendaal.

Intervention

Keyword :
comorbidities, end-of-life care, medication

Outcome measures

Primary outcome

interview material

Secondary outcome

nvt

Background summary

use of medication for comorbid diseases in terminal care.

Study objective

to focus on the patient objectives about medication use for comorbid diseases
at the end of life.

Study design

open interviews, 60 minutes,

Study burden and risks

no risks and no direct benefits for the patient him/herself

Public
stichting Groenhuysen

Kalsdonksestraat 89
Roosendaal 4702 ZB
NL
Scientific
stichting Groenhuysen

Kalsdonksestraat 89
Roosendaal 4702 ZB
NL

Listed location countries

Netherlands

Age

Adults (18-64 years)
Elderly (65 years and older)

Inclusion criteria

admitted to an hospice or palliative care unit in a nursing home

Exclusion criteria

not able to undergo an interview

Design

Study type :
Observational non invasive
Masking :
Open (masking not used)
Control :
Uncontrolled
Primary purpose :
Health services research

Recruitment

NL
Recruitment status
:
Recruiting
Start date (anticipated) :
Enrollment :
15
Type :
Actual

Approved WMO
Date :
Application type :
First submission
Review commission :
CMO regio Arnhem-Nijmegen (Nijmegen)
Approved WMO
Date :
Application type :
Amendment
Review commission :
CMO regio Arnhem-Nijmegen (Nijmegen)

Followed up by the following (possibly more current) registration

No registrations found.

Other (possibly less up-to-date) registrations in this register

No registrations found.

In other registers

Register ID
CCMO NL41648.091.12